Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of disodium fospropofol injection for induction and maintenance of general anesthesia
ChiCTR2500105371Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of fospropofol disodium (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Success rate of maintaining general anesthesia and Incidence of respiratory tract obstruction after extubation. Started Jul 2025; status: recruiting.
02
Drugs
fospropofol disodium
Beyond the preview
Go deeper on ChiCTR2500105371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105371.